UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
PUT
Vertex Pharmaceuticals
VRTX
$123B
| $31.1M | 0.01% |
66,300
-14,600
| -18% | -$6.34M |
|
1352
Restaurant Brands International
QSR
$25.8B
| $31M | 0.01% |
440,398
-8,973
| -2% | -$641K |
|
1353
Lennox International
LII
$15.4B
| $31M | 0.01% |
57,894
-5,562
| -9% | -$2.74M |
|
1354
CALL
Target
TGT
$67.1B
| $30.9M | 0.01% |
208,900
-17,800
| -8% | -$2.8M |
|
1355
Rivian
RIVN
$22.5B
| $30.9M | 0.01% |
2,302,912
+243,068
| +12% | +$2.54M |
|
1356
Lincoln National
LNC
$8.98B
| $30.9M | 0.01% |
992,441
+258,285
| +35% | +$7.81M |
|
1357
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.75B
| $30.8M | 0.01% |
200,288
-32,242
| -14% | -$4.84M |
|
1358
FIVE9
FIVN
$2.28B
| $30.8M | 0.01% |
699,106
+496,386
| +245% | +$25.8M |
|
1359
CALL
Zscaler
ZS
$26.1B
| $30.7M | 0.01% |
159,978
+72,306
| +82% | +$12.9M |
|
|
JBGS
1360
JBG SMITH
JBGS
$711M
| $30.7M | 0.01% |
2,018,459
+963,801
| +91% | +$14.3M |
|
1361
CALL
Ferrari
RACE
$71.5B
| $30.6M | 0.01% |
75,000
+15,000
| +25% | +$6.24M |
|
1362
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.81B
| $30.6M | 0.01% |
416,025
-1,085
| -0.3% | -$82K |
|
1363
Fidelity National Financial
FNF
$13.8B
| $30.5M | 0.01% |
616,700
-2,535
| -0.4% | -$128K |
|
1364
PUT
Capri Holdings
CPRI
$1.84B
| $30.4M | 0.01% |
920,200
+120,100
| +15% | +$4.34M |
|
1365
Nuveen Municipal Credit Income Fund
NZF
$2.42B
| $30.4M | 0.01% |
2,463,320
-27,820
| -1% | -$334K |
|
1366
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.78B
| $30.4M | 0.01% |
1,211,289
+22,166
| +2% | +$552K |
|
1367
Owens Corning
OC
$12.3B
| $30.4M | 0.01% |
174,886
+30,252
| +21% | +$5.24M |
|
1368
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
| $30.4M | 0.01% |
305,325
-913
| -0.3% | -$90.6K |
|
1369
CALL
Wells Fargo
WFC
$270B
| $30.3M | 0.01% |
510,256
-277,300
| -35% | -$16.4M |
|
1370
CALL
Caterpillar
CAT
$401B
| $30.3M | 0.01% |
90,900
-4,600
| -5% | -$1.6M |
|
1371
Charles River Laboratories
CRL
$12.6B
| $30.3M | 0.01% |
146,442
+25,295
| +21% | +$5.73M |
|
1372
NiSource
NI
$20.6B
| $30.2M | 0.01% |
1,048,883
+146,600
| +16% | +$4.14M |
|
1373
Natural Resource Partners
NRP
$1.39B
| $30.2M | 0.01% |
336,678
-1,599
| -0.5% | -$144K |
|
1374
ProShares Russell 2000 Dividend Growers ETF
SMDV
$710M
| $30.2M | 0.01% |
485,330
+31,847
| +7% | +$1.98M |
|
|
1375
CALL
Vertex Pharmaceuticals
VRTX
$123B
| $30.1M | 0.01% |
64,300
+1,600
| +3% | +$694K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.